RUSSO, ROBERTO
 Distribuzione geografica
Continente #
NA - Nord America 4.899
AS - Asia 4.863
EU - Europa 4.137
SA - Sud America 615
Continente sconosciuto - Info sul continente non disponibili 231
AF - Africa 135
OC - Oceania 14
Totale 14.894
Nazione #
US - Stati Uniti d'America 4.702
SG - Singapore 2.086
RU - Federazione Russa 1.671
IT - Italia 1.032
VN - Vietnam 986
CN - Cina 903
BR - Brasile 498
HK - Hong Kong 328
FR - Francia 227
DE - Germania 216
NL - Olanda 180
FI - Finlandia 178
IE - Irlanda 143
CA - Canada 124
SE - Svezia 121
GB - Regno Unito 109
BD - Bangladesh 96
JP - Giappone 68
IN - India 67
TR - Turchia 56
UA - Ucraina 56
CI - Costa d'Avorio 43
KR - Corea 40
AR - Argentina 36
PL - Polonia 36
MX - Messico 34
ZA - Sudafrica 33
ES - Italia 32
PH - Filippine 25
IQ - Iraq 24
EC - Ecuador 21
PK - Pakistan 21
TH - Thailandia 21
AT - Austria 20
CZ - Repubblica Ceca 20
AE - Emirati Arabi Uniti 17
VE - Venezuela 16
TW - Taiwan 15
ID - Indonesia 14
AU - Australia 12
CO - Colombia 11
EE - Estonia 11
LT - Lituania 11
EG - Egitto 10
MT - Malta 10
PY - Paraguay 10
BG - Bulgaria 9
HU - Ungheria 9
NP - Nepal 9
BE - Belgio 8
JM - Giamaica 8
MA - Marocco 8
UZ - Uzbekistan 8
AM - Armenia 7
CL - Cile 7
IL - Israele 7
JO - Giordania 7
KZ - Kazakistan 7
MY - Malesia 6
PE - Perù 6
SA - Arabia Saudita 6
TT - Trinidad e Tobago 6
BO - Bolivia 5
KE - Kenya 5
PS - Palestinian Territory 5
PT - Portogallo 5
SK - Slovacchia (Repubblica Slovacca) 5
TN - Tunisia 5
BH - Bahrain 4
CR - Costa Rica 4
GR - Grecia 4
HN - Honduras 4
MK - Macedonia 4
NI - Nicaragua 4
UY - Uruguay 4
XK - ???statistics.table.value.countryCode.XK??? 4
AZ - Azerbaigian 3
DO - Repubblica Dominicana 3
DZ - Algeria 3
GA - Gabon 3
GT - Guatemala 3
IR - Iran 3
LB - Libano 3
NG - Nigeria 3
NO - Norvegia 3
RO - Romania 3
RS - Serbia 3
SN - Senegal 3
SY - Repubblica araba siriana 3
AL - Albania 2
BZ - Belize 2
ET - Etiopia 2
EU - Europa 2
GH - Ghana 2
GN - Guinea 2
KG - Kirghizistan 2
KH - Cambogia 2
KW - Kuwait 2
LK - Sri Lanka 2
MO - Macao, regione amministrativa speciale della Cina 2
Totale 14.631
Città #
Singapore 994
San Jose 624
Chandler 457
Ashburn 428
Moscow 414
Hong Kong 319
Beijing 293
Naples 281
Ho Chi Minh City 275
Hanoi 203
Amsterdam 150
Santa Clara 141
Los Angeles 139
Napoli 121
Hefei 113
Millbury 104
Lauterbourg 100
The Dalles 100
Dallas 87
New York 84
Princeton 81
Council Bluffs 77
Munich 72
Nanjing 72
Boston 68
Dong Ket 66
Jacksonville 61
Tokyo 56
Turku 56
Des Moines 53
Buffalo 50
Ottawa 46
Wilmington 46
Da Nang 45
São Paulo 44
Redondo Beach 42
Woodbridge 40
Haiphong 39
Orem 39
Helsinki 34
Frankfurt am Main 33
Seattle 33
Denver 32
Dublin 31
Dearborn 29
Chicago 28
Warsaw 28
Houston 27
Milan 27
Montreal 27
Brooklyn 26
London 26
Rome 25
Atlanta 24
Seoul 24
Lawrence 21
Nanchang 20
Stockholm 20
Brno 18
Toronto 18
Falkenstein 17
Rio de Janeiro 17
Cagliari 16
Phoenix 16
San Francisco 16
Ninh Bình 15
Shenyang 15
Menlo Park 14
Florence 13
Johannesburg 13
Poplar 13
Belo Horizonte 12
Boardman 12
Can Tho 12
Kronberg 12
Lappeenranta 12
Norwalk 12
Pomigliano d'Arco 12
Ankara 11
Bacoli 11
Biên Hòa 11
Brasília 11
Changsha 11
Guangzhou 11
Mumbai 11
Tallinn 11
Baghdad 10
Dhaka 10
Hebei 10
Jiaxing 10
Mexico City 10
Charlotte 9
Cleveland 9
Curitiba 9
Manchester 9
Melita 9
Paris 9
Pune 9
Shanghai 9
Thái Bình 9
Totale 7.499
Nome #
Palmitoylethanolamide treatment reduces blood pressure in spontaneously hypertensive rats: involvement of cytochrome p450-derived eicosanoids and Renin Angiotensin system 266
Phaseolus vulgaris L. Extract: Alpha-amylase inhibition against metabolic syndrome in mice 223
Sex-related alterations of gut microbiota composition in the BTBR mouse model of autism spectrum disorder. 216
Hydroxytyrosol prevents metabolic impairment reducing hepatic inflammation and restoring duodenal integrity in a rat model of NAFLD. 214
Galactosylated Pro-Drug of Ursodeoxycholic Acid: Design, Synthesis, Characterization, and Pharmacological Effects in a Rat Model of Estrogen-Induced Cholestasis 214
Chemopreventive effect of a milk whey by-product derived from Buffalo (Bubalus bubalis) in protecting from colorectal carcinogenesis 208
Pharmacokinetic characteristics and pharmacological profile of polyethylenglicole derivatives of palmitoylethanolamide (PEA) 194
Analgesic properties of N-(1-carbomyl 2-phenyl-ethyl)butyramide a new synthetic butyrate pro-drug in a model of acute and visceral pain 191
Butyrate as bioactive human milk protective component against food allergy 190
Gut-brain axis: Role of lipids in the regulation of inflammation, pain and CNS diseases 187
N-(1-carbamoyl-2-phenyl-ethyl) butyramide, a new synthetic butyrate derivative, reduces intestinal inflammation in dextran sodium sulphate-induced colitis 184
Specific gut microbiome signatures and the associated pro-inflamatory functions are linked to pediatric allergy and acquisition of immune tolerance 179
In vivo bioavailability and in vitro toxicological evaluation of the new butyric acid releaser N-(1-carbamoyl-2-phenyl-ethyl) butyramide 174
Characterization of New TRPM8 Modulators in Pain Perception 170
Acute intracerebroventricular administration of palmitoylethanolamide, an endogenous peroxisome proliferator-activated receptor-alpha agonist, modulates carrageenan-induced paw edema in mice. 169
Polyethylene glycol derivatives of palmitoylethanolamide and analogous acylethanolamides 169
Aceclofenac-Galactose Conjugate: Design, Synthesis, Characterization, and Pharmacological and Toxicological Evaluations 165
Improvement of Topical Palmitoylethanolamide Anti-Inflammatory Activity by Pegylated Prodrugs 162
Multiple drug-delivery strategies to enhance the pharmacological and toxicological properties of Mefenamic acid 161
Alginate-hyaluronan composite hydrogels accelerate wound healing process. 154
Palmitoylethanolamide counteracts autistic-like behaviours in BTBR T+tf/J mice: Contribution of central and peripheral mechanisms 154
Fatty acid acyl ethanolamines and PPAR-alpha in neurodegenerative and neurological diseases. Cellular models of neurodegeneration: preliminary data 153
Motor coordination and synaptic plasticity deficits are associated with increased cerebellar activity of NAPDH oxidase, CAMKII, and PKC at pre-plaque stage in the TgCRND8 mouse model of Alzheimer's disease. 153
Identification of an acetal derivative of the piperonyl methyl ketone in tablets seized for suspected drug trafficking 152
The Hepatic Mitochondrial Alterations Exacerbate Meta-Inflammation in Autism Spectrum Disorders 151
Peroxisome proliferator-activated receptor (PPAR)-alpha activation produces antidepressant-like effects in mice 151
Derivati polietilenglicolici di palmitoiletanolammide e aciletanolammidi analoghe 150
Targeting gut dysbiosis against inflammation and impaired autophagy in Duchenne muscular dystrophy 149
Oral sodium butyrate supplementation ameliorates paclitaxel-induced behavioral and intestinal dysfunction 149
Central administration of oxytocin reduces hyperalgesia in mice: Implication for cannabinoid and opioid systems. 149
N-(1-carbamoyl-2-phenyl-ethyl) butyramide, a new synthetic butyrate derivative, reduces intestinal inflammation in dextran sodium sulfate-induced colitis 149
Comparative therapeutic effects of sodium butyrate and BuToRo® in a model of nonalcoholic steatohepatitis in the young rat 149
Therapeutic effects elicited by the probiotic Lacticaseibacillus rhamnosus GG in children with atopic dermatitis. The results of the ProPAD trial 146
Ketogal Safety Profile in Human Primary Colonic Epithelial Cells and in Mice 145
Role of sodium butyrate and of its new prodrug N-(1-carbamoyl-2-phenyl-ethyl) butyramide (FBA) in gastrointestinal transit, castor oil-induced diarrhoea, and croton oil-induced intestinal inflammation 144
Menthol-derived isoxazoles reduce capsaicin-induced allodynia in mice when applied as cutaneous gel 144
An orally administered butyrate-releasing derivative reduces neutrophil recruitment and inflammation in dextran sulphate sodium-induced murine colitis 142
Preventive and curative effect of a synbiotic-based Lactobacillus paracasei B21060 on dextran sodium sulfate-induced colitis in mice 141
Uncovering the role of the lipid receptor PPAR-alpha on higher brain functions 141
Improving in vivo conversion of oleuropein into hydroxytyrosol by oral granules containing probiotic Lactobacillus plantarum 299v and an Olea europaea standardized extract 141
Paclitaxel binds and activates C5aR1: A new potential therapeutic target for the prevention of chemotherapy-induced peripheral neuropathy and hypersensitivity reactions 138
Paracetamol-Galactose Conjugate: A Novel Prodrug for an Old Analgesic Drug 138
Behavioral, Anti-Inflammatory, and Neuroprotective Effects of a Novel FPR2 Agonist in Two Mouse Models of Autism 138
The Influence of Fiber on Gut Microbiota: Butyrate as Molecular Player Involved in the Beneficial Interplay Between Dietary Fiber and Cardiovascular Health 137
Sodium butyrate and its synthetic amide derivative modulate nociceptive behaviors in mice 136
N-Palmitoylethanolamide protects the kidney from hypertensive injury in spontaneously hypertensive rats via inhibition of oxidative stress 135
Antiepileptic action of N-palmitoylethanolamine through CB1 and PPAR-α receptor activation in a genetic model of absence epilepsy. 135
Role of β3-adrenergic receptor in the modulation of synaptic transmission and plasticity in mouse cerebellar cortex 135
Palmitoylethanolamide Protects Against the Amyloid-β25-35-Induced Learning and Memory Impairment in Mice, an Experimental Model of Alzheimer Disease. 133
Ketogal: A Derivative Ketorolac Molecule with Minor Ulcerogenic and Renal Toxicity 133
Rapid broad-spectrum analgesia through activation of peroxisome proliferator-activated receptor-alpha. 132
High Amylose Wheat Bread at Breakfast Increases Plasma Propionate Concentrations and Reduces the Postprandial Insulin Response to the Following Meal in Overweight Adults 131
Exploration of TRPM8 Binding Sites by β-Carboline-Based Antagonists and Their In Vitro Characterization and In Vivo Analgesic Activities 131
Palmitoylethanolamide, a lipid mediator, controls feeding behaviour and restores leptin sensitivity in ovariectomized obese rats 129
Peroxisome proliferator-activated receptor alpha plays a crucial role in behavioral repetition and cognitive flexibility in mice 127
Anxiolytic-Like Properties of the Anandamide Transport Inhibitor AM404. 126
Pharmacokinetic-pharmacodynamic influence of N-palmitoylethanolamine, arachidonyl-2′-chloroethylamide and WIN 55,212-2 on the anticonvulsant activity of antiepileptic drugs against audiogenic seizures in DBA/2 mice 126
Galactosylated Prodrugs: A Strategy to Improve the Profile of Nonsteroidal Anti-Inflammatory Drugs 125
Effects of Histone Deacetylase Inhibitors on the Development of Epilepsy and Psychiatric Comorbidity in WAG/Rij Rats 125
Nanoparticles prolong N-palmitoylethanolamide anti-inflammatory and analgesic effects in vivo 125
role of neurosteroids in the analgesic and anti-hyperalgesic effect of pea 124
Effects of sodium butyrate and its synthetic amide derivative on liver inflammation and glucose tolerance in an animal model of steatosis induced by high fat diet. 123
Galactosyl prodrug of palmitoylethanolamide: Synthesis, stability, cell permeation and cytoprotective activity 123
First evidence of altered microbiota and intestinal damage and their link to absence epilepsy in a genetic animal model, the WAG/Rij rat 123
Implication of allopregnanolone in the antinociceptive effect of N-palmitoylethanolamide in acute or persistent pain. 121
Antinociceptive effect of two novel transient receptor potential melastatin 8 antagonists in acute and chronic pain models in rat 121
Effects of Chronic Oral Probiotic Treatment in Paclitaxel-Induced Neuropathic Pain 119
Galactosylated prodrugs of non-steroidal anti-inflammatories with improved pharmacokinetic characteristics and reduced toxicity of the starting drug 118
Palmitoylethanolamide modulates pentobarbital-evoked hypnotic effect in miceInvolvement of allopregnanolone biosynthesis. 116
Palmitoylethanolamide prevents metabolic alterations and restores leptin sensitivity in ovariectomized rats 116
Modulation of neuropathic and inflammatory pain by the endocannabinoid transport inhibitor AM404 [N-(4-hydroxyphenyl)-eicosa-5,8,11,14-tetraenamide]. 115
The search for the palmitoylethanolamide receptor. 114
Biological Profile of Two Gentiana lutea L. Metabolites Using Computational Approaches and In Vitro Tests 114
Pharmacological propertis of N-(1-carbomyl 2-phenyl-ethyl)butyramide a new synthetic butyrate pro-drug in inhibiting gastrointestinal transit, castor oil induced diarrhoea and dextran sulfate sodium (DSS)-induced colitis 113
DF2726A, a new IL-8 signalling inhibitor, is able to counteract chemotherapy-induced neuropathic pain 113
PALMITOYLETHANOLAMIDE, AN ENDOGENOUS PPAR-α AGONIST, MODULATES NEUROSTEROIDS DE NOVO SYNTHESIS 111
central ppar-alpha activation reduces pain and hyperalgesia in mice via nuclear factor kb inhibitor 110
Synthesis and Pharmacological Evaluation of Analogs of Indole-Based Cannabimimetic Agents. 109
The nuclear receptor peroxisome proliferator-activated receptor-alpha mediates the anti-inflammatory actions of palmitoylethanolamide. 108
The safety assessment of herbals with a new and ethical approach 108
Galactosyl prodrug of ketorolac: synthesis, stability, and pharmacological and pharmacokinetic evaluations 107
The Beneficial Effects of Ultramicronized Palmitoylethanolamide in the Management of Neuropathic Pain and Associated Mood Disorders Induced by Paclitaxel in Mice 106
Anandamide suppresses pain initiation through a peripheral endocannabinoid mechanism 106
Central administration of palmitoylethanolamide reduces hyperalgesia in mice via inhibition of NF-kappaB nuclear signalling in dorsal root ganglia. 105
Design, synthesis and in vitro and in vivo biological evaluation of flurbiprofen amides as new fatty acid amide hydrolase/cyclooxygenase-2 dual inhibitory potential analgesic agents 105
involvment of opioid and cannabinoid receptors in the oxytocin-induced antiyhperalgesic effect following icv administration 104
Inhibition of C5aR1 as a promising approach to treat taxane-induced neuropathy 104
PALMITOYLETHANOLAMIDE INDUCES NEUROSTEROIDS SYNTHESIS IN C6 CELLS TROUGH PPAR-ALPHA DEPENDENT MECHANISM 103
Phaseolus vulgaris extract ameliorates high-fat diet-induced colonic barrier dysfunction and inflammation in mice by regulating peroxisome proliferator-activated receptor expression and butyrate levels 102
naples pain conference (NPC) 99
PPAR-ALPHA AND NF-KB ACTIVATION. IMPLICATION IN PAIN PRINCIPIATION AND CHRONIC PAIN ESTABLISHMENT. 97
Modulation of Pain Sensitivity by Chronic Consumption of Highly Palatable Food Followed by Abstinence: Emerging Role of Fatty Acid Amide Hydrolase 97
Farmacologia delle aciletanolamidi: da cannabinomimetici a ppar-α agonisti nella modulazione del dolore 95
Endogenous acylethanolamides modulates pain perception in mice 95
Selective N-acylethanolamine-hydrolyzing acid amidase inhibition reveals a key role for endogenous palmitoylethanolamide in inflammation. 94
INVOLVEMENT OF OPIOID AND CANNABINOID RECEPTORS IN THE OXYTOCIN-INDUCED ANTIHYPERALGESIC EFFECT FOLLOWING ICV ADMINISTRATION 92
Palmitoylethanolamide protects mice against 6-OHDA-induced neurotoxicity and endoplasmic reticulum stress: In vivo and in vitro evidence 92
Effects of a new synthetic butyrate derivate N-(1-Carbamoyl-2-phenyl-ethyl) butyramide on dextran sodium sulphate-induced colitis in mice 91
Palmitoylethanolamide Stimulation Induces Allopregnanolone Synthesis in C6 Cells and Primary Astrocytes: Involvement of Peroxisome-Proliferator Activated Receptor-α. 90
Synergistic antinociception by the cannabinoid receptor agonist anandamide and the PPAR-alpha receptor agonist GW7647. 86
Totale 13.667
Categoria #
all - tutte 48.101
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 48.101


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022735 0 2 2 45 20 28 14 29 128 36 193 238
2022/20231.182 111 58 49 122 140 132 24 120 167 155 71 33
2023/2024689 29 112 105 52 30 61 46 103 11 19 82 39
2024/20253.639 184 138 18 67 90 171 438 266 204 338 1.403 322
2025/20266.718 716 403 726 670 1.218 265 756 315 760 508 180 201
2026/2027364 279 85 0 0 0 0 0 0 0 0 0 0
Totale 14.894